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Purpose: To report unusual ocular manifestations of branchio-oculo-facial syndrome (BOFS) caused by a novel mutation
in activating enhancer binding protein 2 alpha (TFAP2A).
Methods: Full ophthalmological evaluation and direct sequencing of TFAP2A.
Results: A 10-year-old girl with unusual ocular manifestations of BOFS such as elliptical shaped microcornea and a novel
de novo TFAP2A mutation was identified.
Conclusions: This report expands the ocular phenotypic spectrum of BOFS and adds to the small number of reported
TFAP2A mutations.
In 1987, Fujimoto et al. [1] described an apparently novel
syndrome  that  combines  branchial  sinus,  ocular,  and
craniofacial anomalies and appropriately named it branchio-
oculo-facial  syndrome  (BOFS  OMIM  113620).  Branchial
sinus defects are usually in the form of cervical/infra-auricular
skin defects. Craniofacial defects include pseudo-cleft/cleft
lip, broad nasal bridge, and high forehead. Pseudo-cleft is a
particularly helpful clinical feature that is highly specific to
this syndrome. Ocular features are more diverse and include
microphthalmia,  lacrimal  duct  obstruction,  and  coloboma
[2].  Since  the  original  description,  81  cases  have  been
reported, and while the phenotype was believed by many to
be  quite  distinct,  others  have  been  more  skeptical  [3].  In
particular,  the  overlap  with  branchio-oto-renal  syndrome
(BORS) has raised doubts that BOFS may in fact be an allelic
disorder  [3].  Both  disorders  are  autosomal  dominant  and
affect  branchial  structures,  but  the  two  developmental
disorders, despite their extreme phenotypic variability, do
have quite different predilection to certain organs, such as the
kidney in the case of branchio-oto-renal syndrome and the eye
in the case of BOFS. However, it was the identification of
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activating  enhancer  binding  protein  2  alpha  (TFAP2A)
mutations  in  patients  with  BOFS  that  provided  the
unequivocal proof that BOFS is indeed a distinct clinical
entity [4].
Since the original description of TFAP2A as the disease
gene, very few subsequent reports have been published. In this
study, we describe a girl with molecularly confirmed BOFS
and  who  also  has  unusual  ocular  manifestations  that  we
believe expand the ocular phenotype of this syndrome.
METHODS
Human  subjects:  The  patient  was  recruited  with  written
informed consent (KFSHRC IRB #2070023) and had full
ophthalmological  and  dysmorphological  evaluations.  The
parents were also recruited with written informed consent to
determine whether the mutation is familial or de novo. The
patient  and  her  parents  were  recruited  at  King  Khalid
University Hospital.
Mutation analysis: Genomic DNA was extracted from the
patient and her parents (5 ml of blood in EDTA from each
individual) and kept at 4 degrees until processed for DNA
extraction the following day. On the patient’s sample, all
TFAP2A  coding  exons  as  well  as  their  flanking  intronic
sequences  were  PCR  amplified  on  MyCycler  (Bio-Rad,
Hercules, CA) (primer sequences and PCR conditions are
available upon request). On the parental samples, a targeted
PCR amplification of the mutation-containing fragment was
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813performed.  Amplicons  were  purified  then  bidirectionally
sequenced  on  an  ABI  3730xl  DNA  Analyzer  (Applied
Biosystems,  Foster  City,  CA).  Sequence  analysis  was
performed using DNA Star package (Lasergene, Madison,
WI).
RESULTS
Clinical evaluation: The index is a 10-year-old girl who was
referred to our clinical genetics service for evaluation because
of her craniofacial dysmorphia. She was born at term to a 35-
year-old gravida 8 para 7 mother following an uneventful
Figure  1.  Clinical  photographs  of  the
patient.  Facial  appearance  with  the
typical pseudocleft of the upper lip is
shown in A. Microcornea, inferonasal
coloboma, and cataract are shown in B
and C. Lateral facial profile is shown in
D.
Figure 2. A novel mutation in TFAP2A. Sequence chromatogram of the patient is shown in A and B (forward and reverse) and that of her
parents in C and D (forward only) with the c.763A>T mutation indicated by a red asterisk. Protein alignment across species in E shows very
strong conservation of the R255 residue which is indicated by the red arrow.
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814pregnancy.  Delivery  was  spontaneous,  vaginal,  and
uncomplicated. At birth multiple anomalies were noted in the
form of a high-arched palate and partial cutis aplasia in the
right   retroauricular  region.  Apparent  microphthalmia
prompted a full ophthalmological evaluation that revealed the
additional  presence  of  microcornea,  iris  and  chorioretinal
coloboma, inferiorly subluxed lenses with mild cataractous
changes on the left, and nasolacrimal duct stenosis. High
resolution karyotype was normal 46,XX and subtelomeric
fluorescence  in  situ  hybridization  (FISH)  was  normal.
Metabolic screening, echocardiogram, and kidney ultrasound
were also normal. Magnetic resonance imaging of the eyes
performed  at  the  age  of  4  years  revealed  an  abnormal
configuration of both eye globes, with evidence of a triangular
shape  of  the  lenses  (which  are  displaced  medially  and
inferiorly), small coloboma at the posterior aspect of both eye
globes, normal symmetric appearance of both optic nerves,
and normal extraocular muscles. She had mild speech delay,
probably  related  to  mild  to  moderate  hearing  loss,  but  is
currently doing well in regular school where she is in an age-
matched grade; her IQ was measured to be 85.
Physical examination at 10 years of age revealed a small
body build, with height at 127.5 cm (between the 5th and 10th
centiles), weight at 20.4 kg (<5%), and head circumference at
49.6 cm (just above the 2nd percentile). In addition to the
previously documented ocular anomalies, she has pseudocleft
of  the  upper  lip,  oligodontia,  mixed  hearing  loss,  and
abnormal orientation of the nasal spine, which appears flushed
with the forehead (Figure 1). There is partial cutis aplasia in
the right retroauricular region, but  the neck appears normal
otherwise.  The  rest  of  the  physical  examination  was
essentially  normal.   Specifically,  there is  no evidence of
chest,  spine,  nail,  or  hair abnormalities. A repeat ophthal-
mological examination revealed the following:
1-  Visual  acuity:  Searching  and  wandering  eye
movement. She did not fix or follow light or objects.
Cycloplegic refraction through the phakic part is −1.50
for the right eye and −1.50 for the left eye.
2- Intraocular pressure: Right eye 17 mmHg and left
eye 25 mmHg.
3-  Slit-lamp  examination:  Microphthalmia
bilaterally, clear but elliptical cornea bilaterally, anterior
chamber is deep and quiet, iris shows a large coloboma
bilaterally inferiorly with lens opacity. In addition, the
lens appeared to be slightly subluxated inferiorly with
zonules on both sides showing superiorly.
Figure 3. Summary of previously reported TFAP2A mutations. A schematic of the TFAP2A gene is shown in A along with the genomic location
of previously reported mutations. B and C show two different isoforms of the protein encoded by TFAP2A (AP2) along with the location of
previously reported mutations at the protein level. The mutation in the current study is indicated by red asterisk. PG: proline/glutamine rich
domain, B: basic DNA binding domain, HSH: helix span helix domain.
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24- Fundus examination: Showed a large chorioretinal
coloboma in both eyes. B-scan ultrasound confirmed a
chorioretinal coloboma close to the disc in both eyes, but
no  retinal  detachment  or  any  other  pathology  was
appreciated.
Mutation analysis: A novel heterozygous TFAP2A missense
mutation in exon 4, c.763A>T, was detected that results in
replacement  of  basic  arginine  by  nonpolar  tryptophan
(p.Arg255Trp; Figure 2). This mutation was confirmed on the
reverse direction and on repeat PCR on the patient but not on
her parents (paternity was verified), thus confirming the de
novo nature of this mutation (Figure 2). The mutation affects
a highly conserved amino acid residue (Figure 3) and was not
found  in  a  panel  of  106  Saudi  normal  controls  (212
chromosomes), further supporting its pathogenic nature.
DISCUSSION
Ocular manifestations of BOFS are variable, as shown in
Table 1, with microphthalmia, coloboma, and nasolacrimal
duct stenosis being the most common. To our knowledge, the
appearance  of  an  elliptical-shaped  cornea  has  never  been
reported  in  association  with  BOFS.  Other  unusual  eye
findings  in  our  patient  include  lens  subluxation  and
microcornea, which have only been observed in three BOFS
patients to date (Table 1) [2-21].
The  identification  of  TFAP2A  as  the  disease  gene  in
BOFS provided long sought answers to the ocular phenotype
of this syndrome. TFAP2A is a retinoic acid responsive gene
that  encodes  activating  enhancer-binding  protein  2  alpha
(AP-2α), a member of the AP-2 family of transcription factors
that regulate gene expression during embryogenesis of the
eye, ear, face, body wall, limbs, and neural tube [4]. The role
of AP-2α in eye development has been established in several
studies,  perhaps  the  most  compelling  of  which  is  the
demonstration that Tfap2a knockout mouse embryos exhibit
grossly  abnormal  ocular  development  in  the  form  of
anophthalmia, aphakia, absent cornea, coloboma, lens stalk,
lack of ciliary body and iris formation, absent eyelids, and
ectopic neural retina that replaces part of the retinal pigmented
epithelium [22,23].
Mechanistic insight into some of these anomalies comes
from a more complicated set of data. For instance, targeted
deletion  of  Tfap2a  in  the  murine  lens  placode  reduced
cadherin 1 (Cdh1) expression and increased epidermal growth
factor  receptor  (Egfr)  and  alpha  smooth  muscle  actin  (α-
SMA)  expression,  indicating  abnormal  lens  epithelial
mesenchymal  transformation,  which  may  explain  the
occurrence  of  cataract  [24].  In  another  study  [25]  double
heterozygous mice for paired box gene 6 (Pax6) and Tfap2a
showed  a  more  severe  ocular  phenotype  than  single
heterozygotes  in  the  form  of  persistent  lens  stalk  or  lens
protrusion  into  the  cornea,  which  suggests  cooperation
between the two transcription factors in lens development. On
the other hand, insight into the mechanism of the observed
posterior segment defects comes from a zebrafish study that
examined  how  partial  abrogation  of  Tfap2a  affects  the
expressivity of ocular phenotypes. Knockdown of either bone
morphogenetic protein 4 (Bmp4) or transcription factor 7-like
1a (Tcf7l1a), which encode a Bmp ligand and a transcriptional
effector of Wnt signaling, respectively, do not cause an ocular
phenotype. However, partial knockdown of Tfap2a in either
of these two mutants led to abnormal ocular development in
the form of coloboma, anophthalmia, and microphthalmia,
thus establishing a genetic interaction between Tfap2a and
these two genes [17].
In the first TFAP2A mutation report by Milunsky et al.
[4], a total of five mutations were described, one of which was
a  large  genomic  deletion  and  the  remaining  four  were
missense  mutations  mainly  in  exon  4.  Three  subsequent
papers  described  a  total  of  six  mutations:  one  indel,  one
deletion, one large genomic deletion, and three missense [4,
17,20,21] (Figure 3). Mutation analysis of TFAP2A in our
patient showed a de novo novel mutation in exon 4, a mutation
hotspot that encodes the basic region of the DNA-binding
domain [4]. Four of the five TFAP2A mutations in the original
paper by Milunsky et al. [4] were also de novo, and this
mutation affects the same residue (R255) described in that
paper but results in a different substitution. Both our mutation
(R255W) and that by Milunsky et al. [4] (R255G) replace the
positively charged arginine with nonpolar amino acids in the
DNA-binding domain, which is likely to adversely affect the
capacity of TFAP2A to bind DNA. Although no functional
validation  was  performed,  the  fact  that  the  TFAP2A
mutational spectrum is not exclusive to missense mutations is
highly suggestive of haploinsufficiency as the most likely
mechanism. However, the finding that gain of function N-
ethyl-N-nitrosourea-induced mutation in mouse results in a
highly similar ocular phenotype to that observed in the Tfap2a
knockout  mouse  leaves  open  the  possibility  that  some
missense mutations may in fact mediate their effect in human
BOFS patients by increasing TFAP2A transcriptional activity
[26].
In summary, we add one novel mutation to the allelically
heterogeneous disorder of BOFS and describe unusual eye
findings that expand the ocular phenotype of this disorder.
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